DRUG DISCOVERY ONLINE EDITORIAL ADVISORY BOARD

Drug discovery is entering a new era, one defined by AI, advanced biology, new approach methodologies, novel therapeutic modalities, and an unprecedented pace of innovation.

The Drug Discovery Online Editorial Advisory Board brings together a global community of experts spanning target discovery, computational biology, screening, lead optimization, translational medicine, biologics, cell and gene therapies, investing, and drug development leadership.

Their collective expertise helps guide our editorial direction, spotlight emerging breakthroughs, and foster meaningful conversations across the worldwide drug discovery ecosystem.

If you’re serious about where drug discovery is going and you'd like to be considered for membership? Reach out to Ray Dogum.

Adam Arterbery, Founder and Principal
Agistarr Consulting
 
Shruthi Bharadwaj, Executive Director, Head of AI Drug Discovery Analytics
Revolution Medicines
 
Brian Doehle, Senior Officer Drug Development
Gates Foundation
 
Joanne Kamens, CEO
Women In Bio
Chinmay Kommuru, Venture Advisor
Aayaam Bio
Zaher Nahle, Senior Scientific Advisor (CHE)/Founder & CEO (Ivyctory Group)
Center for a Humane Economy (CHE) & The Ivyctory Group
Michael Phelan, Principal Consultant
InnovApproach Consulting
Bojana Popovic, Discovery Team Lead
Cambridge Crystallographic Data Centre
Ester Caffarel-Salvador, Director, Strategic Innovation
Chiesi USA
Srijit Seal, Principal Scientist
Human Chemical Company
Hiroshi Sugimoto, Director
Takeda Development Center Americas Inc.